Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion type Assertion NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_head.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion description "[We analyzed TMPRSS2-ERG gene rearrangement status by fluorescence in situ hybridization in 521 cases of clinically localized surgically treated prostate cancer with 95 months of median follow-up and also in 40 unmatched metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_provenance.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion evidence source_evidence_literature NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_provenance.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion SIO_000772 19190343 NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_provenance.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion wasDerivedFrom befree-20150227 NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_provenance.
- NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_assertion wasGeneratedBy ECO_0000203 NP522229.RAd5s92kTc8E1WcF2WUOhuyyC-A3TVofF5xK3H8cot_qc130_provenance.